Nakayama C, Wataya Y, Santi D V, Saneyoshi M, Ueda T
J Med Chem. 1981 Oct;24(10):1161-5. doi: 10.1021/jm00142a008.
A number of 1-(5-phospho-beta-D-arabinosyl)-5-substituted-uracils (ara-UMP's) have been examined as inhibitors of dTMP synthetase. As reversible inhibitors, all were substantially less potent than their 2'-deoxyribosyl counterparts. In the presence of 5,10-methylenetetrahydrofolate (CH2-H4folate), ara-FUMP caused a first-order, time-dependent inactivation of the enzyme. At 0 degrees C, kinetic studies indicated a reversible Kd of 3.6 micro M for the ara-FUMP-CH2-H4folate complex, and k = 0.22 min-1 for the subsequent inactivation. Spectral studies of the complex and its behavior toward protein denaturants demonstrate that its structure and stoichiometry are directly analogous to those which have previously been described for FdUMP. The significance of this finding with regard to prodrugs of ara-FU and the potential of ara-FU as a chemotherapeutic agent are discussed.
已对多种1-(5-磷酸-β-D-阿拉伯糖基)-5-取代尿嘧啶(ara-UMP)作为胸苷酸合成酶抑制剂进行了研究。作为可逆抑制剂,所有这些化合物的效力均远低于其2'-脱氧核糖基类似物。在5,10-亚甲基四氢叶酸(CH2-H4叶酸)存在下,ara-FUMP导致该酶发生一级时间依赖性失活。在0℃时,动力学研究表明ara-FUMP-CH2-H4叶酸复合物的可逆解离常数Kd为3.6 μM,随后失活的速率常数k = 0.22 min-1。对该复合物及其对蛋白质变性剂的行为进行的光谱研究表明,其结构和化学计量与先前描述的FdUMP直接类似。讨论了这一发现对于ara-FU前药的意义以及ara-FU作为化疗药物的潜力。